NDC 0173-0901
Sotrovimab
Sotrovimab
Sotrovimab is a Intravenous Injection, Solution, Concentrate in the Human Prescription Drug category. It is labeled and distributed by Glaxosmithkline Llc. The primary component is Sotrovimab.
| Product ID | 0173-0901_55b0f153-afab-4e61-9e68-6674f99d1ebe |
| NDC | 0173-0901 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sotrovimab |
| Generic Name | Sotrovimab |
| Dosage Form | Injection, Solution, Concentrate |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2021-05-26 |
| Marketing Category | UNAPPROVED DRUG OTHER / |
| Labeler Name | GlaxoSmithKline LLC |
| Substance Name | SOTROVIMAB |
| Active Ingredient Strength | 63 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |